Thought Leadership
Fortune 500 Pharma Company Meets Critical Deadlines with TransPerfect Life Sciences’ COA Solutions
“The team has been wonderful and I’ve been so lucky to have worked with them on this. It really does take a village to keep a study of this magnitude afloat so it really is me that should be extending my gratitude.”...
Shaping The Future of eCOA/ePRO
We have witnessed a rapid and dramatic migration from paper to electronic COA/PRO in the past few years. TransPerfect Life Sciences' C3 Summit brings to you virtual sessions on how the paper to digital migration is evolving, the use and application of eCOA migration...
Successful English Build & Language Migration
Over the past decade, the global clinical trial landscape has changed drastically. A surge in technological innovation, including wearable devices, patient portals, and apps, has modernized how clinical data is collected and managed. With pen and paper becoming obsolete in the...
3 Translation Methodologies for Life Sciences Documentation
This post outlines three translation methodologies for life sciences documentation, emphasizing their importance due to the complexity and specific needs of clinical documentation translation. It describes standard translation, back translation & reconciliation, and...
How Life Sciences Companies Can Detect Adverse Events on Social Media
An overview of the evolving role of social media in pharmacovigilance (PV) for pharmaceutical companies, highlighting how social media platforms have become crucial sources for adverse event reporting and post-marketing safety information, and outlining the challenges and...
ISPOR Europe 2020 Virtual Poster - Usability Testing for eCOAs
In order to ensure a fluid experience for a patient, usability testing is a critical data point to consider. Addressing both a patient’s needs and access to a digital platform is key to data collection. TransPerfect, along with our partners from Parexel, Clinical Ink, and...
The Paper Chase - Clinical Outcome Assessments in the Digital Age
Patients are, at last, gaining a voice in healthcare. Stakeholders have come to recognize that patients have valuable information to share about their experiences with diseases and medications that should influence policy and treatment decisions. The U.S. Food & Drug...
Swimming in a Data Lake of eCOA Wearables
We all know there is a significant increase in data collected from wearable sensors, but what does that mean for eCOA? In our latest whitepaper , Mark Wade, Global Practice Leader for TransPerfect Life Sciences examines the considerations of adopting these sensors as an addition...
Wearables for eCOA: Practical Considerations for Improving Patient Data Capture
This electronic clinical outcome assessment (eCOA) webinar will explore the latest advancements in wearable technology and their potential to improve patient data collection in clinical studies. While there may still be ongoing discussions around deployment and standardization,...